International conference on cell and gene therapy
September 22-24, 2026 | Dubai
Register Now Abstract
September 22-24, 2026 | Dubai
Register Now Abstract
September 22-24, 2026 | Dubai
Erat ipsum justo amet duo et elitr dolor, est duo duo eos lorem sed diam stet diam sed stet.
Erat ipsum justo amet duo et elitr dolor, est duo duo eos lorem sed diam stet diam sed stet.
Erat ipsum justo amet duo et elitr dolor, est duo duo eos lorem sed diam stet diam sed stet.
We are pleased to invite you to join us at the International Conference on Cell and Gene Therapy 2026, scheduled to take place from 22–24 September 2026 in the vibrant and innovative city of Dubai, UAE. Recognized as a leading Gene Therapy Conference Dubai 2026, this prestigious event will bring together global experts and innovators working at the forefront of advanced biomedical science and therapeutic development.
The Cell and Gene Therapy Forum Dubai will serve as a premier platform for sharing the latest breakthroughs in cell therapy, gene therapy, regenerative medicine, and next-generation therapeutic technologies. As one of the most anticipated Advanced Therapies Conference Dubai events of the year, the conference will unite leading scientists, clinicians, biotechnology innovators, regulatory experts, and industry pioneers from across the world.
As cell and gene therapies continue to transform the future of healthcare, this Gene Therapy Summit UAE will provide a unique opportunity for participants to exchange cutting-edge research, explore clinical advancements, discuss regulatory developments, and discover emerging trends that are shaping the next generation of precision and personalized medicine.
Join us in Dubai for three days of high-level scientific sessions, global networking opportunities, and meaningful collaboration as we collectively advance innovation and shape the future of cell and gene therapy.
Gene therapy offers groundbreaking potential to treat—and in some cases, possibly cure—a wide spectrum of genetic and acquired diseases once considered untreatable. Its applications are expanding quickly, from monogenic conditions like sickle cell disease and hemophilia to more complex disorders including certain cancers and neurodegenerative diseases.
Gain firsthand exposure to the newest discoveries in cell and gene therapy, including emerging genome engineering tools, next-generation vectors, and advanced therapeutic platforms.
Learn directly from internationally recognized scientists, clinicians, and industry pioneers as they present transformative research, clinical insights, and future-driven perspectives.
Engage with a diverse agenda covering every dimension of cell and gene therapy—from fundamental science and translational research to clinical applications, manufacturing, and regulatory evolution.
Participate in interactive panel sessions where experts dissect challenges, share real-world experiences, and explore solutions to critical scientific and clinical questions.
Connect with global leaders, innovators, early-career researchers, biotech professionals, investors, and decision-makers—expanding your professional network and potential collaborations.
Identify partnership opportunities for joint research, technology development, clinical studies, commercialization efforts, and multidisciplinary initiatives.
Stay ahead of the curve with updates on cutting-edge technologies shaping the field, including CRISPR advancements, cell engineering tools, RNA-based therapies, automation, and AI-powered innovations.
Join conversations that will help define the next era of cell and gene therapy, contributing to discussions that shape scientific progress, regulatory policy, and the future of patient care.
CEOs, Directors, Founders, and Senior Leadership from biotech, pharma, and healthcare organizations
Leading researchers, principal investigators, laboratory scientists, and academic scholars
Physicians, geneticists, clinical trial specialists, and healthcare practitioners involved in advanced therapeutics
Professionals from R&D, manufacturing, regulatory affairs, quality control, and commercialization teams
Representatives from government agencies, health authorities, and policy advisory bodies
Deans, department heads, senior faculty members, and research administrators
Founders and innovators developing next-generation gene and cell therapy solutions
Members of NGOs, international health bodies, and advocacy groups focused on genetic and rare diseases
Graduate students, postdoctoral researchers, and early-career professionals entering the field
Financial leaders interested in funding emerging cell and gene therapy technologies
Science journalists, medical writers, and communication specialists covering biotech innovation
Experts in AI, bioinformatics, computational biology, and advanced therapeutic technologies
Developers of tools supporting gene delivery, cell processing, and laboratory research
Scientists and teams working on advanced biologics, RNA platforms, and new therapeutic modalities
Tempor erat elitr rebum at clita. Diam dolor diam ipsum sit. Aliqu diam amet diam et eos. Clita erat ipsum et lorem et sit, sed stet lorem sit clita duo justo magna dolore erat amet
Design Approach
Innovative Solutions
Project Management
Read More
Tempor erat elitr rebum at clita. Diam dolor diam ipsum sit. Aliqu diam amet diam et eos. Clita erat ipsum et lorem et sit, sed stet lorem sit clita duo justo magna dolore erat amet
Call Us Now
Mail Us Now
Clita clita tempor justo dolor ipsum amet kasd amet duo justo duo duo labore sed sed. Magna ut diam sit et amet stet eos sed clita erat magna elitr erat sit sit erat at rebum justo sea clita.
Clita clita tempor justo dolor ipsum amet kasd amet duo justo duo duo labore sed sed. Magna ut diam sit et amet stet eos sed clita erat magna elitr erat sit sit erat at rebum justo sea clita.
Clita clita tempor justo dolor ipsum amet kasd amet duo justo duo duo labore sed sed. Magna ut diam sit et amet stet eos sed clita erat magna elitr erat sit sit erat at rebum justo sea clita.